25 Participants NeededMy employer runs this trial

Patient Navigation Program for Young Cancer Survivors

EE
CE
Overseen ByCorrine E. Munoz-Plaza, MPH
Age: 18 - 65
Sex: Any
Trial Phase: Academic
Sponsor: Kaiser Permanente
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

The investigators propose to: 1) Adapt an evidence-based cancer-focused patient navigation (PN) program for the Adolescent and Young Adult (AYA) cancer survivor population; and 2) Plan and conduct an effectiveness-implementation trial of this program within Kaiser Permanente Southern California (KPSC). PLEASE NOTE: This study is awarded in two phases. The UG3 phase has been awarded for the first two years; upon successful completion of this phase by meeting pre-defined milestones, the National Cancer Institute (NCI) will provide funding for the second phase of the study (Years 3-6), which will allow our team to conduct a trial to determine the effectiveness of the implementation of the adapted PN program for the AYA cancer survivor population. This application is focused on the initial UG3 phase and will update the protocol for the UH3 trial upon successful completion of the UG3 milestones and receipt of the UH3 award.

The primary objectives in the UG3 phase of the study are to adapt and tailor an existing PN program to meet the needs of AYA cancer survivors and the local clinical context via (a) interviews with key stakeholders (patients, clinicians, administrators) and (b) guidance from our AYA Primary Care Survivorship Council. The investigators will conduct a pilot study of the adapted PN program and refine the program to enhance acceptability to patients and clinicians, enhance feasibility and effectiveness, and develop and pilot evaluation tools and methods prior to the start of the UH3 phase of the trial, which will be a larger trial. Objectives will be updated for the UH3 phase once awarded.

Who Is on the Research Team?

EE

Erin E Hahn, PhD

Principal Investigator

Kaiser Permanente Southern California, Department of Research & Evaluation

Are You a Good Fit for This Trial?

This trial is for people aged 21-45 who have survived cancers such as breast, ovarian, cervical, testicular, colon/rectal, melanoma, endometrial, sarcoma, or thyroid cancer.

Inclusion Criteria

Current Kaiser Permanente insurance coverage
I am between 21 and 45 years old.
I was diagnosed with certain cancers between ages 15 and 39.
See 1 more

Exclusion Criteria

I have been diagnosed with leukemia or lymphoma.
My cancer had already spread when I was first diagnosed.

What Are the Treatments Tested in This Trial?

Interventions

  • Adapted patient navigation program targeting adolescent and young adult cancer survivors

Trial Overview

The study is testing a specially adapted patient navigation program designed to help adolescent and young adult cancer survivors manage their care. The program will be refined based on feedback from patients and healthcare providers.

How Is the Trial Designed?

1

Treatment groups

Experimental Treatment

Group I: Adapted Patient Navigation ProgramExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Kaiser Permanente

Lead Sponsor

Trials
563
Recruited
27,400,000+

National Cancer Institute (NCI)

Collaborator

Trials
14,080
Recruited
41,180,000+